Venlafaxine ER Long-Term Extension Study for Major Depressive Disorder (MDD)
NCT01485887
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
50
Enrollment
INDUSTRY
Sponsor class
Conditions
Major Depressive Disorder
Interventions
DRUG:
Venlafaxine ER
Sponsor
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.